Clincosm LogoSign in Get a demo

transitional cell carcinoma of the bladder

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +4 more
  • Aurora, Colorado
  • +2 more
Apr 18, 2022

Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation

Terminated
  • Bladder Cancer
  • +4 more
  • 3D conformal radiation therapy
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 14, 2022

Bladder Cancer Cell Transitional, Non-Muscle Invasive Bladder Cancer, Bladder Cancer Trial in United States (TSD-001)

Completed
  • Bladder Cancer Cell Transitional
  • +9 more
  • Tucson, Arizona
  • +4 more
Jan 18, 2022

Advanced Solid Tumors, Gastric Cancer, Transitional Cell Carcinoma of the Bladder Trial in Korea, Republic of, Taiwan, United

Completed
Has Results
  • Advanced Solid Tumors
  • +2 more
  • Duarte, California
  • +25 more
Dec 9, 2021

Transitional Cell Carcinoma of the Bladder, Biomarkers Trial in Rotterdam (Pembrolizumab)

Active, not recruiting
  • Transitional Cell Carcinoma of the Bladder
  • Biomarkers
  • Rotterdam, Netherlands
    Erasmus MC
Aug 19, 2021

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Completed
Has Results
  • Distal Urethral Cancer
  • +10 more
  • Gemcitabine hydrochloride
  • +3 more
  • Springfield, Missouri
  • +1 more
Sep 17, 2020

Recurrent Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial in Cleveland (sunitinib malate, immunohistochemistry

Terminated
Has Results
  • Recurrent Bladder Cancer
  • Transitional Cell Carcinoma of the Bladder
  • sunitinib malate
  • +4 more
  • Cleveland, Ohio
  • +1 more
Apr 17, 2019

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
Has Results
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +6 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jul 26, 2018

Recurrent Bladder Cancer, Stage III Bladder Cancer, Stage IV Bladder Cancer Trial in Los Angeles (drug, other, genetic)

Terminated
  • Recurrent Bladder Cancer
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
May 10, 2018

Recurrent Bladder Cancer, Stage 0 Bladder Cancer, Stage I Bladder Cancer Trial in Buffalo (broccoli sprout extract, laboratory

Terminated
Has Results
  • Recurrent Bladder Cancer
  • +4 more
  • broccoli sprout extract
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 31, 2017

Recurrent Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial in Belgium, France

Completed
  • Recurrent Bladder Cancer
  • +2 more
  • Trastuzumab
  • +3 more
  • Bruxelles, Belgium
  • +14 more
Feb 3, 2017

Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial (doxorubicin HCl,

Completed
  • Stage III Bladder Cancer
  • +2 more
  • doxorubicin hydrochloride
  • +5 more
  • (no location specified)
Aug 1, 2016

Transitional Cell Carcinoma of the Bladder Trial in United Kingdom, United States (Gemcitabine, Cisplatin, Sunitinib Malate)

Terminated
Has Results
  • Transitional Cell Carcinoma of the Bladder
  • Gainesville, Florida
  • +4 more
Mar 15, 2016

Transitional Cell Carcinoma of the Bladder Trial in Riyadh (Amino levulinic Acid)

Completed
  • Transitional Cell Carcinoma of the Bladder
  • Amino levulinic Acid
  • Riyadh, Saudi Arabia
    King Khalid University Hospital
Mar 30, 2016

Transitional Cell Carcinoma of the Bladder Trial in Indianapolis, Houston, Norfolk (Dasatinib, Radical Cystectomy)

Completed
Has Results
  • Transitional Cell Carcinoma of the Bladder
  • Indianapolis, Indiana
  • +2 more
Dec 10, 2015

Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial in Ann Arbor (Prostate capsule sparing cystectomy, Nerve

Completed
  • Bladder Cancer
  • Transitional Cell Carcinoma of the Bladder
  • Prostate capsule sparing cystectomy
  • Nerve sparing cystectomy
  • Ann Arbor, Michigan
    University of Michigan
Aug 17, 2015

Adenocarcinoma of the Bladder, Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Trial

Terminated
Has Results
  • Adenocarcinoma of the Bladder
  • +12 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 20, 2014

Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Metastatic Transitional Cell Cancer of

Terminated
  • Advanced Adult Primary Liver Cancer
  • +13 more
  • gemcitabine hydrochloride
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 1, 2013

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +9 more
  • San Francisco, California
    UCSF-Mount Zion
Jun 4, 2013

Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Transitional Cell Carcinoma of the

Completed
  • Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +3 more
  • arsenic trioxide
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jun 3, 2013

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Terminated
  • Distal Urethral Cancer
  • +8 more
  • trastuzumab
  • Chicago, Illinois
    Cancer and Leukemia Group B
May 1, 2013

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Completed
  • Distal Urethral Cancer
  • +10 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Jan 23, 2013

Recurrent Bladder Cancer, Stage I Bladder Cancer, Stage II Bladder Cancer Trial in Houston (Ad5CMV-p53 gene)

Completed
  • Recurrent Bladder Cancer
  • +5 more
  • Ad5CMV-p53 gene
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +5 more
  • trastuzumab
  • +4 more
  • Ann Arbor, Michigan
    University of Michigan University Hospital
Jan 11, 2013